Luca Richeldi Selected Research

Nebulizers and Vaporizers (Inhaler)

1/2024	TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life.
1/2021	The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Richeldi Research Topics

Disease

78	Idiopathic Pulmonary Fibrosis 05/2024 - 09/2010
23	Disease Progression 01/2023 - 09/2010
21	Fibrosis (Cirrhosis) 09/2023 - 09/2011
14	Tuberculosis (Tuberculoses) 12/2019 - 05/2004
13	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2022 - 04/2014
11	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 01/2002
11	Infections 01/2024 - 05/2004
8	COVID-19 01/2024 - 01/2020
8	Lung Diseases (Lung Disease) 01/2022 - 10/2011
6	Pneumonia (Pneumonitis) 10/2023 - 07/2012
5	Sarcoidosis (Schaumann Disease) 01/2022 - 01/2005
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 01/2010
4	Neoplasms (Cancer) 01/2021 - 01/2013
3	Dyspnea (Shortness of Breath) 04/2022 - 11/2018
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Hypoxia (Hypoxemia) 01/2022 - 01/2020
3	Asthma (Bronchial Asthma) 10/2021 - 10/2020
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2019 - 01/2007
3	Diarrhea 10/2019 - 05/2014
3	Bronchiectasis 06/2018 - 01/2017
3	Connective Tissue Diseases (Connective Tissue Disease) 02/2018 - 02/2013
3	Latent Tuberculosis 07/2010 - 04/2006
2	Granuloma 01/2022 - 01/2005
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021 - 07/2012
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 04/2020 - 01/2020
2	Idiopathic Interstitial Pneumonias 01/2020 - 12/2005
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 07/2012
2	Respiratory Sounds (Crackle) 06/2018 - 03/2014
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2014 - 10/2011
2	Latent Infection 06/2011 - 01/2007
2	Pulmonary Tuberculosis 10/2009 - 05/2004
1	Type IV Ehlers-Danlos Syndrome 05/2024
1	Airway Obstruction (Choking) 01/2023
1	Rare Diseases (Rare Disease) 12/2022
1	Cicatrix (Scar) 12/2022
1	Cough 01/2022
1	Critical Illness (Critically Ill) 12/2021
1	Human Influenza (Influenza) 12/2021
1	Fever of Unknown Origin 11/2021
1	Allergic Rhinitis 10/2021

Drug/Important Bio-Agent (IBA)

50	nintedanibIBA 05/2024 - 09/2011
24	pirfenidoneIBA 05/2024 - 09/2010
10	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2009
10	Tuberculin (PPD)IBA 07/2010 - 05/2004
7	GoldIBA 01/2021 - 09/2005
5	Monoclonal AntibodiesIBA 05/2024 - 01/2020
5	SteroidsIBA 01/2023 - 12/2005
5	BI 1015550IBA 01/2023 - 01/2022
5	EnzymesIBA 11/2021 - 08/2004
5	Carbon MonoxideIBA 01/2020 - 09/2013
4	pamrevlumabIBA 05/2024 - 01/2020
4	CollagenIBA 01/2022 - 10/2012
4	AntigensIBA 04/2020 - 01/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2009
4	Interferon-gamma (Interferon, gamma)IBA 07/2010 - 06/2005
3	Formoterol Fumarate (Oxis)FDA Link 01/2024 - 01/2021
3	Oxygen (Dioxygen)IBA 12/2022 - 01/2021
3	Azathioprine (Imuran)FDA LinkGeneric 01/2022 - 05/2004
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 06/2012
3	AutoantibodiesIBA 10/2015 - 01/2013
3	InterferonsIBA 06/2011 - 09/2005
2	Connective Tissue Growth FactorIBA 05/2024 - 01/2020
2	Beclomethasone (Beclometasone)FDA Link 01/2024 - 01/2021
2	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2024 - 01/2021
2	COVID-19 VaccinesIBA 01/2024 - 01/2022
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 01/2013
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2023 - 01/2022
2	C-Reactive ProteinIBA 04/2022 - 10/2021
2	Antifibrotic AgentsIBA 01/2022 - 09/2021
2	CytokinesIBA 01/2022 - 07/2010
2	Phosphotransferases (Kinase)IBA 01/2022 - 10/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 05/2014 - 04/2014
2	lipoarabinomannan (LAM)IBA 01/2014 - 10/2011
1	Collagen Type III (Type III Collagen)IBA 05/2024
1	VaccinesIBA 01/2024
1	P-SelectinIBA 09/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	fibrin fragment D (D-dimer)IBA 04/2022
1	NitrogenIBA 04/2022
1	Urea (Carbamide)FDA LinkGeneric 04/2022
1	Phosphodiesterase 4 InhibitorsIBA 01/2022
1	Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric 01/2022
1	CC-90001IBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	chitotriosidaseIBA 11/2021
1	SodiumIBA 10/2021

Therapy/Procedure

36	Therapeutics 02/2024 - 05/2004
3	Lung Transplantation 01/2023 - 12/2018
3	Drug Therapy (Chemotherapy) 03/2022 - 01/2013
3	Traction 06/2018 - 01/2017
2	Precision Medicine 02/2024 - 01/2016
2	Nebulizers and Vaporizers (Inhaler) 01/2024 - 01/2021
2	Critical Care (Surgical Intensive Care) 12/2021 - 01/2020
1	Palliative Care (Palliative Therapy) 01/2023